The chemosensitizer cyclosporin A enhances the toxic side-effects of doxorubicin in the rat

W. Van de Vrie, A. M. Jonker, R. L. Marquet, A. M.M. Eggermont

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

10 Citaten (Scopus)


the feasibility of using chemosensitizers in the circumvention of P-glycoprotein-mediated multidrug resistance has been shown in many studies. We recently reported on the chemosensitizing effect of cyclosporin A (CsA) on doxorubicin in a rat solid tumour model. Using the same experimental design we investigated the side-effects of the combination treatment. During the 35-day experiment doxorubicin treatment caused dose-dependent weight loss, which was enhanced by combination treatment with CsA. The main doxorubicin-related side-effects were myelosuppression (transient leucopenia and thrombopenia) and nephrotoxicity. Damage to the kidney was severe, leading to a nephrotic syndrome and resulting in ascites, pleural effusion, hypercholesterolaemia and hypertriglyceridaemia. These toxicities were enhanced by the addition of the chemosensitizer CsA. Mild doxorubicin-related cardiomyopathy and minimal hepatotoxicity were seen on histological examination. There were no signs of enhanced toxicity of the combination treatment in tissues with known high expression levels of P-glycoprotein, like the liver, adrenal gland and large intestine. CsA had a low toxicity profile, as it only caused a transient rise in bilirubin. In conclusion, the chemosensitizer CsA enhanced the side-effects of the anticancer drug doxorubiein without altering the toxicity pattern. There was no evidence of a therapeutic gain by adding CsA to doxorubicin, compared to single-agent treatment with doxorubicin in 25%-33% higher doses, because of the enhanced toxicity of the combination treatment.

Originele taal-2Engels
Pagina's (van-tot)533-538
Aantal pagina's6
TijdschriftJournal of Cancer Research and Clinical Oncology
Nummer van het tijdschrift9
StatusGepubliceerd - sep. 1994
Extern gepubliceerdJa


Duik in de onderzoeksthema's van 'The chemosensitizer cyclosporin A enhances the toxic side-effects of doxorubicin in the rat'. Samen vormen ze een unieke vingerafdruk.

Citeer dit